<DOC>
	<DOCNO>NCT00277524</DOCNO>
	<brief_summary>The purpose OMNI study characterize therapy diagnostic utilization study participant implant study device describe Implantable Cardioverter Defibrillator ( ICD ) therapy utilization life threaten arrhythmias primary secondary prevention study participant . This study ass therapy Medtronic pacemaker , defibrillator , cardiac resynchronization therapy device . The first therapy reduce unnecessary pacing pacemaker patient . The second therapy provide pace therapy attempt stop fast life threaten ventricular arrhythmia lieu deliver defibrillation shock . The third therapy diagnostic measurement patient 's fluid status provide physician information patient 's heart failure status . The study also assess time patient 's first defibrillation shock verify shock fast life threaten ventricular rhythm .</brief_summary>
	<brief_title>OMNI Study -- Assessing Therapies Medtronic Pacemaker , Defibrillator , Cardiac Resynchronization Therapy Devices .</brief_title>
	<detailed_description>The OMNI result demonstrate importance Medtronic 's ongoing effort increase adoption evidence base shock-reduction programming strategy . Longer VF NID ( number interval detect VF zone ) utilize Anti-tachycardia Pacing ( ATP ) During Charging Feature . ATP Charging allow physician treat ATP without delay shock . Therefore , VF NID may extend allow episode chance self-terminate immediately shock use ATP charge feature .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Bradycardia</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Implant new replacement study device . Enrollment must occur later 40 day postimplant . Study participant must 18 year age old . Study participant enrol intend participate another clinical device trial course study require specific treatment programming . Study participant unwilling unable comply followup schedule .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Pacemaker</keyword>
	<keyword>Defibrillator</keyword>
	<keyword>Cardiac Resynchronization</keyword>
	<keyword>Dysynchrony</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Arrhythmia</keyword>
	<keyword>Tachycardia</keyword>
	<keyword>Bradycardia</keyword>
</DOC>